Personalized cancer approach: using RNA interference technology.
about
PDX1 associated therapy in translational medicinePancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.Neurotrophic Factor Artemin Promotes Invasiveness and Neurotrophic Function of Pancreatic Adenocarcinoma In Vivo and In Vitro.Pancreatic cancer actionable genes in precision medicine and personalized surgery.
P2860
Personalized cancer approach: using RNA interference technology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Personalized cancer approach: using RNA interference technology.
@en
Personalized cancer approach: using RNA interference technology.
@nl
type
label
Personalized cancer approach: using RNA interference technology.
@en
Personalized cancer approach: using RNA interference technology.
@nl
prefLabel
Personalized cancer approach: using RNA interference technology.
@en
Personalized cancer approach: using RNA interference technology.
@nl
P2093
P2860
P1476
Personalized cancer approach: using RNA interference technology.
@en
P2093
Donald D Rao
F Charles Brunicardi
John Nemunaitis
Shi-He Liu
P2860
P2888
P304
P356
10.1007/S00268-011-1100-0
P577
2011-08-01T00:00:00Z